Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by Tumbleweed67on Jun 12, 2010 11:44am
579 Views
Post# 17183233

BoD

BoDOkay, I will bring this up so the bashers can't accuse us "pumpers" of hiding facts.
It appears one of our BoD may have sold his position in the company yesterday.
This is obviously an interesting and concerning development. Is he stepping down? Being replaced?
Just MORE questions to be answered. Don't think I'd be expecting results to be released for at least a few more days though.

GLTA
TW
Bullboard Posts